Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Cytomegalovirus Infection

Free Subscription Articles published in Bone Marrow Transplant Retrieve available abstracts of 17 articles: HTML format

Single Articles

May 2025
1. KUNO M, Tanaka T, Maeshima AM, Takamaru H, et al
   Prognostic impact of histopathologic features including histological grading and immunohistochemistry-positive cell counts in cytomegalovirus-gastrointestinal disease after allogeneic hematopoietic cell transplantation.
   Bone Marrow Transplant. 2025 May 20. doi: 10.1038/s41409-025-02621.
   PubMed    
   
   
   
2. LIBERATORE C, D'Uva M, Natale A, Guardalupi F, et al
   Cytomegalovirus infection after autologous transplantation in patients with multiple myeloma exposed to daratumumab.
   Bone Marrow Transplant. 2025 May 13. doi: 10.1038/s41409-025-02624.
   PubMed    
   
   
   
3. ZAMORA D, Xie H, Wong E, Santiano C, et al
   ELISPOT as a predictor of clinically significant cytomegalovirus infection after hematopoietic cell transplantation in letermovir recipients.
   Bone Marrow Transplant. 2025 May 6. doi: 10.1038/s41409-025-02611.
   PubMed     Abstract available
   
   
   March 2025
4. ZHEN S, Liu L, Zhang X, Wang J, et al
   Increased Epstein-Barr virus reactivation but similar incidence of post-transplant lymphoproliferative disorders due to pre-emptive rituximab therapy following allogeneic hematopoietic stem cell transplantation in the letermovir era for cytomegaloviru
   Bone Marrow Transplant. 2025 Mar 3. doi: 10.1038/s41409-025-02542.
   PubMed    
   
   
   January 2025
5. WANG Q, Liu M, Zhang S, Gao L, et al
   Letermovir prophylaxis for cytomegalovirus in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation.
   Bone Marrow Transplant. 2025 Jan 7. doi: 10.1038/s41409-024-02502.
   PubMed    
   
   
   November 2024
6. ALEXANDER T, Badoglio M, Labopin M, Daikeler T, et al
   Monitoring and management of CMV and EBV after autologous haematopoietic stem cell transplantation for autoimmune diseases: a survey of the EBMT Autoimmune Diseases Working party (ADWP).
   Bone Marrow Transplant. 2024 Nov 7. doi: 10.1038/s41409-024-02461.
   PubMed    
   
   
   July 2024
7. ESTEVE M, Albert E, Gimenez E, Colomer E, et al
   Assessment of Cytomegalovirus DNA doubling time and virus-specific T-cell responses in the management of CMV infection in allogeneic hematopoietic stem cell transplant recipients undergoing Letermovir prophylaxis.
   Bone Marrow Transplant. 2024 Jul 20. doi: 10.1038/s41409-024-02376.
   PubMed    
   
   
   May 2024
8. PFEIFFER T, Lockowitz CR, Shenoy S, Mavers M, et al
   Letermovir as cytomegalovirus prophylaxis in children undergoing allogeneic hematopoietic cell transplantation.
   Bone Marrow Transplant. 2024 May 21. doi: 10.1038/s41409-024-02315.
   PubMed    
   
   
   January 2024
9. GALAVERNA F, Baccelli F, Zama D, Tridello G, et al
   Letermovir for Cytomegalovirus infection in pediatric patients undergoing allogenic hematopoietic stem cell transplantation: a real-life study by the Infectious Diseases Working Group of Italian Association of Pediatric Hematology-Oncology (AIEOP).
   Bone Marrow Transplant. 2024 Jan 25. doi: 10.1038/s41409-024-02209.
   PubMed     Abstract available
   
   
   
10. BASHEY SZ, Solomon SR, Zhang X, Morris LE, et al
    Letermovir prophylaxis lowers the incidence of Non-CMV infections after allogeneic hematopoietic cell transplantation.
    Bone Marrow Transplant. 2024 Jan 23. doi: 10.1038/s41409-024-02201.
    PubMed    
    
    
    November 2023
11. MALAGOLA M, Radici V, Farina M, Pellizzeri S, et al
    Correction: CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2023 Nov 29. doi: 10.1038/s41409-023-02158.
    PubMed    
    
    
    October 2023
12. MALAGOLA M, Radici V, Farina M, Pellizzeri S, et al
    CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2023 Oct 19. doi: 10.1038/s41409-023-02124.
    PubMed    
    
    
    
13. OROFINO G, Xue E, Doglio M, Noviello M, et al
    Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovir.
    Bone Marrow Transplant. 2023;58:1104-1111.
    PubMed     Abstract available
    
    
    August 2023
14. KABUT T, Weinbergerova B, Folber F, Lengerova M, et al
    High-dose aciclovir in CMV infection prophylaxis after allogeneic HSCT: a single-center long-term experience.
    Bone Marrow Transplant. 2023 Aug 23. doi: 10.1038/s41409-023-02081.
    PubMed     Abstract available
    
    
    
15. PRUITT A, Gao F, De Togni E, Cochran H, et al
    Impact of donor age and relationship on outcomes of peripheral blood haploidentical hematopoietic cell transplantation.
    Bone Marrow Transplant. 2023;58:855-862.
    PubMed     Abstract available
    
    
    March 2023
16. EBERHARDT KA, Jung V, Knops E, Heger E, et al
    CMV-IgG pre-allogeneic hematopoietic stem cell transplantation and the risk for CMV reactivation and mortality.
    Bone Marrow Transplant. 2023 Mar 3. doi: 10.1038/s41409-023-01944.
    PubMed     Abstract available
    
    
    December 2022
17. SUN X, Fu H, Wang C, Zhang Y, et al
    Predicting the loss of hepatitis B surface antigen following haematopoietic stem cell transplantation in patients with chronic HBV infection.
    Bone Marrow Transplant. 2022 Dec 1. doi: 10.1038/s41409-022-01880.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cytomegalovirus Infection is free of charge.